NASDAQ: LGNDLigand Pharmaceuticals Inc Stock Ownership - Who owns Ligand Pharmaceuticals?
Insider buying vs selling
Have Ligand Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John W. Kozarich | Director | 2025-07-10 | 934 | $125.00 | $116.75kSell |
| Todd C. Davis | Chief Executive Officer | 2025-06-30 | 233 | $91.08 | $21.22kBuy |
| Andrew Reardon | CLO Secretary | 2025-06-30 | 233 | $91.08 | $21.22kBuy |
| Octavio Espinoza | Chief Financial Officer | 2025-06-30 | 224 | $91.08 | $20.40kBuy |
| Andrew Reardon | CLO Secretary | 2025-06-23 | 500 | $114.08 | $57.04kSell |
| Andrew Reardon | CLO Secretary | 2025-06-10 | 500 | $114.54 | $57.27kSell |
| Martine Zimmermann | Director | 2025-06-06 | 188 | $105.99 | $19.93kSell |
| Andrew Reardon | CLO Secretary | 2025-05-15 | 1,000 | $104.00 | $104.00kSell |
| Todd C. Davis | Chief Executive Officer | 2025-05-09 | 5,523 | $105.67 | $583.63kBuy |
| Octavio Espinoza | Chief Financial Officer | 2025-05-09 | 1,000 | $103.89 | $103.89kBuy |
LGND insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LGND insiders and whales buy or sell their stock.
LGND Shareholders
What type of owners hold Ligand Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Partners L P | 328.26% | 63,334,719 | $7.71B | Insider |
| David M. Knott | 65.36% | 12,611,277 | $1.53B | Insider |
| Daniel S. Loeb | 50.56% | 9,754,756 | $1.19B | Insider |
| Investment 10 LLC | 18.57% | 3,582,065 | $435.94M | Insider |
| Blackrock Inc | 15.14% | 2,920,235 | $355.39M | Institution |
| Vanguard Group Inc | 10.65% | 2,055,732 | $250.18M | Institution |
| Janus Henderson Group PLC | 5.33% | 1,027,549 | $125.05M | Institution |
| Macquarie Group Ltd | 4.70% | 906,227 | $110.29M | Institution |
| Dimensional Fund Advisors LP | 3.86% | 744,930 | $90.66M | Institution |
| State Street Corp | 3.77% | 727,125 | $88.49M | Institution |
LGND vs Biotech Stocks
Ligand Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.